Impact Investing
Vortex Fights Food Waste in Italy
Throwing away food causes a loss of over 22.8 billion euros. Vortex, a company that gives a second life to agri-food waste, is among the winners of the SAES startup acceleration program. Within RedZone, Vortex will have the possibility of introducing an extract (an active ingredient) coming from the ennoblement of waste from the agri-food industry into capsules made with biological materials.
Every Italian wastes 146 kilos of food in a year for an economic value corresponding to €385. Overall, between domestic and industrial waste, 8.65 million tons of food end up wasted per year for an economic value of €22.8 billion. So how can we combat waste in agri-food production? Giving us an answer is Vortex, the startup which, born with the dream of making cosmetics accessible to everyone in a natural, sustainable and circular way, gives a second life to the by-products of the agri-food chain.
The Turin startup is among the winners of the first call RedZone, a technological development program for startups operating in the field of materials science. The heart of its offer are the Open Labs, laboratory and industrial spaces made available by SAES, an Italian company with 80 years of history in advanced materials behind it, where startups can develop, characterize and scale innovative solutions with the support of technicians and company researchers.
If you want to find what is Vortex’s development plan and RedZone’s future projects and to read the most important business news of the day, download for free our companion app Born2Invest.
Vortex ennobles and innovates agri-food by-products
The brand was created in 2020 from the idea of the two founders Lorenzo Picco and Simone Piccolo of wanting to build a business model inspired by the pillars of environmental, economic and social sustainability. The disposal of agri-food by-products today represents an important cost for companies. Vortex aims to find innovative solutions for agri-food by-products, both from an environmental and economic point of view, by ennobling them (upcycling) for the food, nutraceutical and petfood sectors.
“Vortex has demonstrated the potential of its technology through the valorisation of the industrial by-product of the apple cultivar (and not only) by creating firstly an ingredient and secondly a cosmetic brand validated on the market with the name NASTE Beauty” – explained Andrea Cadelli, Ventures RedZone Manager.
The development plan in collaboration with RedZone
“For Vortex, RedZone represents a unique opportunity. It is a program that gives us the opportunity to interact with technicians of the highest level and to access cutting-edge machinery and instrumentation, enabling extremely high-intensity value generation. From this collaboration we expect to be able to launch a competitive project on the market, which will open up new scalability opportunities” stated Lorenzo Picco, CTO of Vortex.
Within RedZone, Vortex will have the possibility of introducing an extract (an active ingredient) coming from the ennoblement of waste from the agri-food industry into capsules made with biological materials, with the aim of creating an effective anti-acne product, sustainable and totally organic.
“The objective of the project is both to create a market MVP from a distribution point of view – he continues – (a finished product) but also to evaluate the application of the same technology in the B2B market.”
New call for startups
Red Zone will open a new call for startups in the first part of 2024, aiming for projects that are highly synergistic with the skills and vision of SAES: “The objective always remains to generate value from the interaction between the agility and dedication of startups towards your project with the technological expertise and industrial capabilities of SAES” – explained Cadelli.
__
(Featured image by TheDigitalArtist via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in StartupItalia, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech1 week ago
Oryzon up 3% After Progress in Trial of Its Drug for Personality Disorder
-
Business2 weeks ago
The Nuanced Differences That Make Specific Online Casinos Stand Apart From Others
-
Biotech7 days ago
Alfasigma Gets Green Light for Commercialization of Jyseleca in Europe
-
Fintech1 week ago
Qonto Launches in Austria and Three Other European Markets